BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17365824)

  • 1. Endometrial carcinoma: pathology and genetics.
    Prat J; Gallardo A; Cuatrecasas M; Catasús L
    Pathology; 2007 Feb; 39(1):72-87. PubMed ID: 17365824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current concepts in the pathology and epigenetics of endometrial carcinoma.
    Arafa M; Somja J; Dehan P; Kridelka F; Goffin F; Boniver J; Delvenne P
    Pathology; 2010 Dec; 42(7):613-7. PubMed ID: 21080868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial carcinoma: molecular alterations involved in tumor development and progression.
    Yeramian A; Moreno-Bueno G; Dolcet X; Catasus L; Abal M; Colas E; Reventos J; Palacios J; Prat J; Matias-Guiu X
    Oncogene; 2013 Jan; 32(4):403-13. PubMed ID: 22430211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetic changes in epithelial, stromal and mixed neoplasms of the endometrium.
    Lax SF
    Pathology; 2007 Feb; 39(1):46-54. PubMed ID: 17365822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular carcinogenesis of endometrial cancer.
    Liu FS
    Taiwan J Obstet Gynecol; 2007 Mar; 46(1):26-32. PubMed ID: 17389185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and pathologic aspects of endometrial carcinogenesis.
    Hecht JL; Mutter GL
    J Clin Oncol; 2006 Oct; 24(29):4783-91. PubMed ID: 17028294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dualistic model of molecular pathogenesis in endometrial carcinoma].
    Lax SF
    Zentralbl Gynakol; 2002 Jan; 124(1):10-6. PubMed ID: 11873308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathology of endometrial carcinoma.
    Matias-Guiu X; Prat J
    Histopathology; 2013 Jan; 62(1):111-23. PubMed ID: 23240673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints.
    Llobet D; Pallares J; Yeramian A; Santacana M; Eritja N; Velasco A; Dolcet X; Matias-Guiu X
    J Clin Pathol; 2009 Sep; 62(9):777-85. PubMed ID: 18977806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endometrial carcinoma and precursor lesions].
    Djordjević B; Stanojević Z
    Srp Arh Celok Lek; 2007; 135(3-4):230-4. PubMed ID: 17642468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular carcinogenesis of ovarian carcinoma].
    Diebold J
    Verh Dtsch Ges Pathol; 2005; 89():77-83. PubMed ID: 18035676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer.
    Shia J; Black D; Hummer AJ; Boyd J; Soslow RA
    Hum Pathol; 2008 Jan; 39(1):116-25. PubMed ID: 17949789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators.
    An HJ; Kim KI; Kim JY; Shim JY; Kang H; Kim TH; Kim JK; Jeong JK; Lee SY; Kim SJ
    Am J Surg Pathol; 2007 Jun; 31(6):846-53. PubMed ID: 17527071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
    Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of the candidate tumor suppressor par-4 in endometrial cancer.
    Moreno-Bueno G; Fernandez-Marcos PJ; Collado M; Tendero MJ; Rodriguez-Pinilla SM; Garcia-Cao I; Hardisson D; Diaz-Meco MT; Moscat J; Serrano M; Palacios J
    Cancer Res; 2007 Mar; 67(5):1927-34. PubMed ID: 17332319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathology of endometrial hyperplasia and endometrial carcinoma: an update.
    Horn LC; Meinel A; Handzel R; Einenkel J
    Ann Diagn Pathol; 2007 Aug; 11(4):297-311. PubMed ID: 17630117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial cancer and somatic G>T KRAS transversion in patients with constitutional MUTYH biallelic mutations.
    Tricarico R; Bet P; Ciambotti B; Di Gregorio C; Gatteschi B; Gismondi V; Toschi B; Tonelli F; Varesco L; Genuardi M
    Cancer Lett; 2009 Feb; 274(2):266-70. PubMed ID: 18980800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular approaches for classifying endometrial carcinoma.
    Piulats JM; Guerra E; Gil-Martín M; Roman-Canal B; Gatius S; Sanz-Pamplona R; Velasco A; Vidal A; Matias-Guiu X
    Gynecol Oncol; 2017 Apr; 145(1):200-207. PubMed ID: 28040204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biology in the clinicopathologic assessment of endometrial carcinoma subtypes.
    Boyd J
    Gynecol Oncol; 1996 May; 61(2):163-5. PubMed ID: 8626127
    [No Abstract]   [Full Text] [Related]  

  • 20. Endometrial cancer--prospective potential to make diagnostic process more specific.
    Repiska V; Radzo E; Biro C; Bevizova K; Bohmer D; Galbavy S
    Neuro Endocrinol Lett; 2010; 31(4):474-6. PubMed ID: 20802453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.